tesamorelin and cjc1295 with ipamorelin tesamorelin+ aod9604 CJC-1295 No DAC & – San Jose Peptides (ARL) + CJC1295 + Ipamorelin TESAMORELIN + CJC-1295 + IPAMORELIN

Potential mild side effects may include: Temporary injection site irritation Mild headache or flushing Increased hunger (typically short-lived) Slight water retention Our clinical team carefully monitors your progress to ensure the therapy remains effective, balanced, and tailored to your needs

Escalating the dose to chase a faster result is explicitly not the studied approach

Related work on the growth hormone axis has examined how secretagogues of this class interact with pituitary signaling

Explored as a possible aid for recovery and lean-mass preservation in frail or catabolic populations, though a Merck-sponsored Phase 2b trial in elderly hip-fracture patients (Adunsky et al., 2011, Archives of Gerontology and Geriatrics, PMID 21067829) was halted early over a cardiac safety signal rather than demonstrating a clear functional benefit

GHRH analogs (sermorelin and tesamorelin) imitate the body's own releasing hormone and bind the GHRH receptor, so the pituitary responds the way it would to a natural signal

Ethics declarations Competing interests D.G.T